Daebongls.Co.,Ltd. reported earnings results for the second quarter and six months ended June 30, 2024. For the second quarter, the company reported sales was KRW 23,577.53 million compared to KRW 21,295.03 million a year ago. Net income was KRW 1,245.55 million compared to KRW 393.23 million a year ago. Basic earnings per share from continuing operations was KRW 114 compared to KRW 36 a year ago. Diluted earnings per share from continuing operations was KRW 114 compared to KRW 36 a year ago. Basic earnings per share was KRW 114 compared to KRW 36 a year ago.
For the six months, sales was KRW 0.00002 million compared to KRW 0.00002 million a year ago. Net income was KRW 2,229.41 million compared to KRW 2,040.9 million a year ago. Basic earnings per share from continuing operations was KRW 204 compared to KRW 186 a year ago. Diluted earnings per share from continuing operations was KRW 204. Basic earnings per share was KRW 204 compared to KRW 174 a year ago.
Daebongls. Co., Ltd. is a Korea-based company engaged in the manufacture of raw materials for pharmaceuticals and cosmetics. The Company operates its business through two main divisions: cosmetic division, which provides aloe vera gels, beta carotens, calamines, diaformers, emulgades and others for conditioners, emulsifiers, emollients, polymers, thickeners and others; pharmaceutical division, which provides almagates, bentonites, calcitriols, erdosteines, fish oil and others for antibiotics, cough products, expectorants and others. In addition, it is involved in the provision of food chemical additives, fish feedstuff and others. The Company distributes its products within domestic market and to overseas markets, including Japan, America and other Southeast Asian countries.
